Latest Articles for Clinical Trials

Qdenga vaccine shows promise in reducing dengue cases, but risks persist for some.

Study evaluates AI's accuracy in identifying neurosurgery study designs.

Incertus.jl streamlines randomization for fair clinical trials across multiple treatments.

Students tackle eye disease detection using AI in a competitive setting.

New methods improve patient grouping for personalized cancer therapies.

This article discusses the importance of replicability in clinical trials using adaptive algorithms.

A study compares daily albendazole with ivermectin for treating loiasis in Gabon.

Learn how treatment effects vary over time in clinical trials.

The SQUEEZE trial investigates fluid management strategies for children with septic shock.

Methods for enhancing analysis in clinical trials using external data sources.

Study identifies key genes linked to survival in lung cancer patients.

GERPACYST seeks to understand pancreatic cysts and their cancer risks.

Researching new treatments through small experiments prioritizes patient safety.

A new algorithm enhances best-arm identification in fixed-budget scenarios.

TLN shows potential in improving symptoms of Parkinson's Disease in trial participants.

Study shows higher doses of corticosteroids offer no benefits for COVID-19 patients needing ventilation.

The Oralytics system aims to assist individuals in better dental care.

A new method improves trials for multiple treatments over time.

Researchers propose a new approach to define and stage Neuronal alpha-Synuclein Disease.

A promising blood test may enhance treatment choices for lung cancer patients.

Focusing on clear questions enhances clinical trial relevance and decision-making.

Research examines how EPA and DHA affect breast tissue health in cancer survivors.

Synthetic data generation can transform clinical trials by ensuring patient privacy and enhancing data availability.

Innovative approaches enhance accuracy in assessing treatment effects via RMST.

NovumRNA helps find hidden cancer targets for better immunotherapy outcomes.

Higher IgE levels may lower glioma risk and improve patient survival.

An analysis questions the necessity of major trials for streptokinase's effectiveness.

Study confirms gene signatures for tailored treatment in head and neck cancer patients.

Researchers develop innovative ways to assess cancer therapy survival rates.

Research focuses on TEAD inhibitors for better mesothelioma therapy options.

NLP models help identify eligibility criteria for cancer clinical trials.

Using past trial data to improve current treatment evaluations.

Researchers aim to improve treatments for stubborn triple-negative breast cancer using gene-targeting techniques.

GATher improves the prediction of drug targets using advanced graph technology.

Study reveals immune profiles predicting treatment outcomes in relapsed EOC patients.

Research aims to refine treatment lengths for tuberculosis.

Study evaluates ComBat's effectiveness in PET imaging for Alzheimer's disease.

This article discusses methods to reduce confounding bias in health outcome studies.

Using machine learning to improve clinical trial eligibility criteria and recruitment.

Research reveals complexities in treating biliary tract cancers and immune interactions.